About AnalytiCon Discovery
AnalytiCon Discovery is a company based in Potsdam (Germany) founded in 2000 was acquired by BRAIN in July 2014. AnalytiCon Discovery has raised $3.04 million across 4 funding rounds from investors including Brain Biotech, European Union and Berlin Capital Fund. AnalytiCon Discovery offers products and services including Screening Libraries and Discovery Services. AnalytiCon Discovery operates in a competitive market with competitors including C2 Pharma, Magellan BioScience Group, Metagreen, BJ Biochem and Alluvium Biosciences, among others.
- Headquarter Potsdam, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Brain Biotech Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.04 M (USD)
in 4 rounds
-
Latest Funding Round
$580.54 K (USD), Grant
Jun 01, 2021
-
Investors
Brain Biotech
& 3 more
-
Employee Count
Not available
-
Acquired by
BRAIN
(Jul 03, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AnalytiCon Discovery
AnalytiCon Discovery offers a comprehensive portfolio of products and services, including Screening Libraries and Discovery Services.
Offers libraries for natural product screening in drug discovery
Provides development and discovery for pharmaceuticals and cosmetics
People of AnalytiCon Discovery
Unlock access to complete
Unlock access to complete
Funding Insights of AnalytiCon Discovery
AnalytiCon Discovery has successfully raised a total of $3.04M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $580.54 thousand completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AnalytiCon Discovery
AnalytiCon Discovery has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Brain Biotech, European Union and Berlin Capital Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Investments are directed by Brandenburg Capital toward multiple sectors.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for AnalytiCon Discovery
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AnalytiCon Discovery
Investment portfolio details for AnalytiCon Discovery
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AnalytiCon Discovery
Detailed financials for AnalytiCon Discovery
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Analyticon Discovery Comparisons
Peer comparison for AnalytiCon Discovery
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AnalytiCon Discovery
AnalytiCon Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as C2 Pharma, Magellan BioScience Group, Metagreen, BJ Biochem and Alluvium Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufactures and distributes active pharmaceutical ingredients and compounds worldwide.
|
|
| Locked | Locked | Locked |
Identifies and develops microbial natural product leads for pharmaceutical and industrial applications
|
|
| Locked | Locked | Locked |
Develops technologies to harness compounds from natural production.
|
|
| Locked | Locked | Locked |
Research and development services for sugar derivatives are provided.
|
|
| Locked | Locked | Locked |
Specializes as a preclinical CRO, developing high-value small molecules derived from natural sources for clients.
|
Detailed competitors of AnalytiCon Discovery
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Analyticon Discovery
Complete news archive for AnalytiCon Discovery
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AnalytiCon Discovery
AnalytiCon Discovery was founded in 2000 and raised its 1st funding round 5 years after it was founded.
AnalytiCon Discovery is headquartered in Potsdam, Germany. It is registered at Potsdam, Brandenburg, Germany.
AnalytiCon Discovery is a funded company, having raised a total of $3.04M across 4 funding rounds to date.
AnalytiCon Discovery was established in 2000 and is headquartered in Potsdam, Germany. Focus is placed on natural products chemistry within the chemical research sector. Services encompass discovery, isolation, and structural elucidation of compounds from natural sources. Operations are conducted through laboratory-based analysis and collaboration on pharmaceutical and biotech projects. The domain ac-discovery.com serves as the primary online presence for these activities.
AnalytiCon Discovery's top competitors include BJ Biochem, Magellan BioScience Group and Synaco Group.
AnalytiCon Discovery offers Screening Libraries and Discovery Services.
AnalytiCon Discovery has 4 investors. Key investors include Brain Biotech, European Union, Berlin Capital Fund, and Brandenburg Capital.